Galectin Therapeutics Inc (GALT) Live Share Price, Invest From India

Galectin Therapeutics Inc Stock Performance

as on March 31, 2026 at 1:05 am IST

Day's Low
Day's High
$2.65
Day's Price Range
$2.69
$2.66
0.38%
Downside
1.13%
Upside
52 Week's Low
52 Week's High
$1.12
52-Week Price Range
$7.13
$2.66
57.89%
Downside
168.05%
Upside

Galectin Therapeutics Inc share price movements today

Previous Close: $2.68
Open: $2.65
Volume: 66.4K
Day's Low - High: $2.65 - $2.69
52 Week Low - High: $1.12 - $7.13

Galectin Therapeutics Inc Historical Returns

1 Month Return: -12.42 %
3 Month Return: -34.31 %
1 Year Return: + 76.32 %
3 Year Return: + 23.5 %
5 Year Return: 0 %

Galectin Therapeutics Inc Stock Fundamentals & Key Indicators

Check Galectin Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$172.8M

EPS (TTM)

-0.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-3727.95%

Galectin Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Galectin Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Galectin Therapeutics Inc	BUY	$172.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.1B	134.86%	136.79	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$110.0B	103.33%	28.25	32.94%
Beone Medicines Ltd	NA	$32.5B	NA	115.05	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	56.74%	17.79	31.41%

Stock Returns calculator for Galectin Therapeutics Inc Stock including INR - Dollar returns

The Galectin Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Galectin Therapeutics Inc investment value today

Current value as on today

₹1,93,925

Returns

₹93,925

(+93.93%)

Returns from Galectin Therapeutics Inc Stock

₹75,000 (+75%)

Dollar Impact

₹18,925 (+18.93%)

Analyst Recommendation on Galectin Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Galectin Therapeutics Inc. Average target price of $11

Galectin Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Galectin Therapeutics Inc.

What analysts predicted

75.82%UPSIDE

Target Price

$11

Current Price

$2.66

Analyzed by

7 Analysts

Target

$11.00

Galectin Therapeutics Inc target price $11, a slight upside of 75.82% compared to current price of $2.66. According to 7 analysts rating.

Galectin Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Galectin Therapeutics Inc Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 28, 2026 to March 30, 2026

Change:-19% versus previous 30 day period

Galectin Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	-	-	-	0	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	0	-
Operating Income	-9	-9	-9	-9	-11	-9	-12	-7	-4	-4
EBITDA	-8	-9	-9	-10	-11	-9	-10	-7	-5	-6
Interest Expense	0	0	0	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-9	-10	-9	-11	-12	-11	-11	-9	-7	-8
Income Tax Expense	0	0	-2	0	-	-	-	-	-	-
Net Income	-9	-10	-9	-11	-12	-11	-11	-9	-7	-8
Net Profit Margin	0.00%	0.00%	-12496.25%	0.00%	0.00%	0.00%	-33241.67%	0.00%	0.00%	0.00%

Galectin Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-20	-21	-16	-13	-13	-23	-30	-38	-38	-42
EBITDA	-20	-21	-16	-13	-13	-23	-29	-37	-38	-41
Interest Expense	-	-	0	0	0	0	0	1	2	5
Depreciation	-	-	0	-	0	0	0	0	0	0
Income Before Tax	-20	-21	-16	-13	-13	-23	-30	-38	-41	-47
Income Tax Expense	-	-	0	-	0	0	0	0	-2	-
Net Income	-20	-21	-16	-13	-13	-23	-30	-38	-41	-47
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galectin Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-10	-9	-11	-12	-11	-11	-9	-7	-8
Operating Cash Flow	-7	-4	-12	-8	-8	-12	-7	-6	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	10	10	10	10	10	0	-	12	1
Change in Cash	2	5	-2	2	1	-11	-7	6	-2

Galectin Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-21	-16	-13	-13	-23	-30	-38	-41	-47
Operating Cash Flow	-16	-15	-10	-10	-20	-24	-31	-32	-41
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	5	3	15	50	0	36	10	40	31
Change in Cash	-10	-12	5	39	-20	12	-21	7	-10

Global Institutional Holdings in Galectin Therapeutics Inc

Funds	Holdings
Susquehanna International Group, LLP	0.69%
Wellington Management Company LLP	0.22%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.	0.2%
Commonwealth Equity Services Inc	0.46%
Marshall Wace Asset Management Ltd	0.93%

See all

Insights on Galectin Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, GALT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 39.1%
NEGATIVE IMPACT
Price Dip
In the last 3 months, GALT stock has moved down by -34.3%

About Galectin Therapeutics Inc

galectin therapeutics (nasdaq: galt) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. drug candidates based on the company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. we use naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. we focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. our strategy is to establish clinical development approaches that add value to the company in the shortest time possible, and to seek partners as the program advances and requires much

Organisation	Galectin Therapeutics Inc
Headquarters	4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Industry	Health Technology
CEO	Mr. Joel Lewis CPA
E-voting on shares	Click here to vote

Key Management of Galectin Therapeutics Inc

Name	Title
Dr. Khurram Jamil M.D.	Chief Medical Officer
Mr. Robert Tritt J.D.	General Counsel
Mr. Jim Wilkins Ph.D.	Head of CMC & Pharmaceutical Development
Ms. Beth Knowles	Executive Assistant & Officer Manager
Mr. Joel Lewis CPA	President & CEO
Mr. Jack W. Callicutt CPA	CFO, Treasurer & Corporate Secretary

FAQs

What is Galectin Therapeutics Inc share price today?

Galectin Therapeutics Inc share price today is $2.66 as on March 30, 2026 at 7:35 pm IST. Galectin Therapeutics Inc share today touched a day high of $2.69 and a low of $2.65.

What is the 52 week high and 52 week low for Galectin Therapeutics Inc share?

Galectin Therapeutics Inc share touched a 52 week high of $7.13 on December 17, 2025 and a 52 week low of $1.12 on April 4, 2025. Galectin Therapeutics Inc stock price today i.e. March 30, 2026 at 7:35 pm IST is trending at $2.66,which is 62.69% down from its 52 week high and 137.50% up from its 52 week low.

What is Galectin Therapeutics Inc's market capitalisation today?

Galectin Therapeutics Inc market capitalisation is $0.00T as on March 30, 2026 at 7:35 pm IST.

How to invest in Galectin Therapeutics Inc Stock (GALT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Galectin Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galectin Therapeutics Inc Shares that will get you 0.5639 shares as per Galectin Therapeutics Inc share price of $2.66 per share as on March 30, 2026 at 7:35 pm IST.

What is the minimum amount required to buy Galectin Therapeutics Inc Stock (GALT) from India?

Indian investors can start investing in Galectin Therapeutics Inc (GALT) shares with as little as ₹94.702 or $1 (as of March 30, 2026 at 7:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Galectin Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 30, 2026 at 7:39 pm IST). Based on Galectin Therapeutics Inc share’s latest price of $2.66 as on March 30, 2026 at 7:35 pm IST, you will get 3.7594 shares of Galectin Therapeutics Inc. Learn more about fractional shares .